Our results show that Th-17 related genes (CTLA4, IL17C, IL17D, IL17E, RORgamma T, FoxP3 and CD70) are expressed in mucosal melanoma. Furthermore, c-kit expression is also increased in the majority of head and neck mucosal melanoma samples from our study. These findings may help establish the role for targeted therapy such as tyrosine kinase inhibitors (Gleevec) and IL-2 in head and neck mucosal melanomas.
Inhibition of AKT Pathway Augments Combination Therapy
Scott Magnuson, MD (presenter); Eben Rosenthal, MD OBJECTIVE: Clinical trials have suggested suppression of EGFR pathway results in improved response to radiotherapy. AKT is a component of the phosphatidylinositol-3 kinase pathway that is downstream of the EGF receptor. Here we perform a preclinical assessment of the augmentation effect of AKT inhibitor on radiotherapy for head and neck squamous cell carcinoma. METHOD: Ex vivo ATP analysis on human tissue samples was performed to measure metabolic activity. Treatment groups were classified as control, AKT inhibitor, cetuximab and AKT i ϩ cetuximab. Nude mice with human SCC1-flank tumor xenografts were treated with combination treatments of 120 mg/kg AKT inhibitor, 10 mg/kg cetuximab, and 2 Gy radiation. Tumor size was assessed after each treatment using a pair of digital calipers. RESULTS: Ex vivo treatment with an AKT inhibitor alone significantly reduced ATP metabolic activity in human tissue specimens compared to control (64%, p ϭ 0.04). Combination treatment with cetuximab further enhanced this effect (29%, pϽ0.01). In vivo SCC1 flank tumor xenografts in Nude mice were significantly smaller following 2 weeks combination treatment with AKT i, cetuximab and radiation (15 mm 2 ) compared to control (102 mm 2 , pϭ0.02) or radiation monotherapy (56 mm 2 , pϭ0.05). CONCLUSION: Inhibition of the AKT pathway augments treatment with cetuximab on ex vivo human tissue and combination treatment with cetuximab and radiation in vivo.
Intraoperative Use of OCT in Endocrine Surgery
William B Armstrong, MD (presenter); Kaveh Naemi, DO; Suzanne Keel, MD; Brian Wong, MD, PhD; Jason H Kim, MD
OBJECTIVE:
To determine the feasibility of the optical coherence tomography (OCT) to image and identify thyroid and parathyroid glands, fat, and lymph nodes in the neck during endocrine surgery. OCT is a high resolution optical imaging modality that generates cross-sectional in turbid media such as living tissue with resolution approaching that of light microscopy. OCT relies upon intrinsic differences in tissue optical properties for image contrast.
METHOD:
In an in vivo, prospective clinical study an OCT imaging system (Niris, Imalux, Cleveland, OH) was used to image structures in the neck in 55 patients during neck surgery. Images were obtained by raster scanning a single mode fiber across the interior of the probe. The imaging probe was sterilized and placed in light contact with the tissue of interest. Images were acquired at a frame rate of 1Hz and resolution of ϳ10 m with a 1 mm depth penetration. Biopsies were performed for later comparison with histology in select cases (nϭ15). RESULTS: OCT demonstrated distinct differences in structural architecture and signal intensity that allowed us to differentiate between thyroid and parathyroid tissues, lymph nodes, and fat. When available, OCT images were compared with histology with good correlation. CONCLUSION: This is the first study to systematically use OCT to differentiate thyroid and parathyroid glands from other structures in the neck. OCT can be used to evaluate these structures, which can be then confirmed with histopathologic evaluation via frozen or permanent sections. In the future, OCT has potential for use as an intraoperative method to more efficiently differentiate thyroid and parathyroid glands, lymph nodes, and fat from one another. And this would potentially obviate the need for frozen section confirmation.
Intrathyroid Parathyroid: The Case against Thyroid Lobectomy
Arnold Goodman, MD (presenter); Douglas Politz, MD; James Norman, MD OBJECTIVE: It is taught that a missing parathyroid adenoma can be within the thyroid, therefore thyroid lobectomy is appropriate when an adenoma cannot be found. Unfortunately, this technique is often futile. The purpose of this study is to examine the frequency of unsuccessful thyroid lobectomy in parathyroid surgery and to look at the true incidence and location of intrathyroid parathyroid adenomas (iT-PA). METHOD: 1163 reoperations for persistent primary hyperparathyroidism (PHPT) were examined for the incidence and outcomes of thyroid lobectomy performed to find iT-PA. A second study examined 10,000 patients undergoing first time parathyroidectomy to classify the location and incidence of iT-PA. RESULTS: Thyroid lobectomy had been previously unsuccessfully performed in 77% of the 1163 cases of PHPT undergoing reoperation. Two or fewer glands were found in 82% prior to lobectomy. The adenoma was subsequently found on the lobectomy side in 64% and on the opposite side in 36%; 99% were in the neck. True iT-PA occurred in only 0.7% of 10,000 primary cases. Another 1.2% were subcapsular or partially within the thyroid substance but visible with meticulous dissection. Mapping showed 90% of iT-PA occurred in the lower, lateral quadrant of the thyroid, with 7% near the recurrent nerve and 3% within the upper pole.
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